• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Emerging and Promising Role of Care for Cardiometabolic Syndrome in Prostate Cancer.

作者信息

Tanaka Atsushi, Node Koichi

机构信息

Department of Cardiovascular Medicine, Saga University, Saga, Japan.

出版信息

JACC CardioOncol. 2019 Dec 17;1(2):307-309. doi: 10.1016/j.jaccao.2019.09.005. eCollection 2019 Dec.

DOI:10.1016/j.jaccao.2019.09.005
PMID:34396197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8352240/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/8352240/c44aa15837b4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/8352240/c44aa15837b4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd3c/8352240/c44aa15837b4/gr1.jpg

相似文献

1
The Emerging and Promising Role of Care for Cardiometabolic Syndrome in Prostate Cancer.心脏代谢综合征护理在前列腺癌中的新兴及前景作用
JACC CardioOncol. 2019 Dec 17;1(2):307-309. doi: 10.1016/j.jaccao.2019.09.005. eCollection 2019 Dec.
2
Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer.目前和未来用于管理前列腺癌雄激素剥夺治疗的代谢并发症的营养策略。
Nutr Res Rev. 2017 Dec;30(2):220-232. doi: 10.1017/S0954422417000087. Epub 2017 Jun 13.
3
Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): Protocol for a Feasibility and Exploratory Efficacy Study in Men on Androgen Deprivation Therapy.前列腺癌综合生活方式改善计划（CLIPP）：雄激素剥夺治疗男性患者可行性和探索性疗效研究方案
JMIR Res Protoc. 2019 Feb 5;8(2):e12579. doi: 10.2196/12579.
4
Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients.雄激素剥夺疗法的开始会导致前列腺癌患者的身体成分、身体机能、心脏代谢健康和生活质量迅速恶化。
Scand J Urol. 2023 Feb-Dec;57(1-6):60-66. doi: 10.1080/21681805.2023.2168050. Epub 2023 Jan 26.
5
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.新诊断雄激素剥夺治疗-naive 前列腺癌男性的低血清睾酮及其与心血管危险因素的关系：RADICAL-PC 亚研究。
J Urol. 2022 May;207(5):1020-1028. doi: 10.1097/JU.0000000000002384. Epub 2022 Jan 3.
6
Cardiovascular Toxicities of Androgen Deprivation Therapy.雄激素剥夺治疗的心血管毒性。
Curr Treat Options Oncol. 2021 Apr 17;22(6):47. doi: 10.1007/s11864-021-00846-z.
7
Metabolic changes in patients with prostate cancer during androgen deprivation therapy.前列腺癌患者在雄激素剥夺治疗期间的代谢变化。
Int J Urol. 2018 Jan;25(1):45-53. doi: 10.1111/iju.13473. Epub 2017 Oct 20.
8
Risk of cardiovascular intervention after androgen deprivation therapy in prostate cancer patients with a prior history of ischemic cardiovascular and cerebrovascular disease: A nationwide population-based cohort study.前列腺癌患者既往有缺血性心血管和脑血管疾病史后行雄激素剥夺治疗的心血管介入风险：一项基于全国人群的队列研究。
Urol Oncol. 2022 Jan;40(1):6.e11-6.e19. doi: 10.1016/j.urolonc.2021.07.002. Epub 2021 Jul 24.
9
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分：晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
10
Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer.前列腺癌雄激素剥夺治疗的代谢和心血管风险
Expert Rev Endocrinol Metab. 2010 Jul;5(4):531-537. doi: 10.1586/eem.10.35.

引用本文的文献

1
[Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study.[吕]Lu-PSMA-617 作为转移性去势抵抗性前列腺癌患者的一线全身治疗：一项真实世界研究。
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2495-2503. doi: 10.1007/s00259-024-06677-y. Epub 2024 Mar 12.
2
Prevalence and temporal trends of prostate diseases among inpatients with cardiovascular disease: a nationwide real-world database survey in Japan.心血管疾病住院患者中前列腺疾病的患病率及时间趋势：日本一项全国性真实世界数据库调查
Front Cardiovasc Med. 2023 Oct 19;10:1236144. doi: 10.3389/fcvm.2023.1236144. eCollection 2023.
3

本文引用的文献

1
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer.雄激素剥夺疗法治疗前列腺癌的心血管效应。
Curr Oncol Rep. 2019 Aug 24;21(10):91. doi: 10.1007/s11912-019-0841-z.
2
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease.比较 GnRH 激动剂和 GnRH 拮抗剂在伴有心血管疾病的晚期前列腺癌患者中的心血管发病率的随机临床试验
J Urol. 2019 Dec;202(6):1199-1208. doi: 10.1097/JU.0000000000000384. Epub 2019 Jun 12.
3
Androgen deprivation therapy and cardiovascular disease.
Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.
癌症及其疗法的性别特异性心血管风险。
Circ Res. 2022 Feb 18;130(4):632-651. doi: 10.1161/CIRCRESAHA.121.319901. Epub 2022 Feb 17.
4
Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer.美国前列腺癌退伍军人心血管危险因素的评估与管理
JAMA Netw Open. 2021 Feb 1;4(2):e210070. doi: 10.1001/jamanetworkopen.2021.0070.
雄激素剥夺疗法与心血管疾病。
Urol Oncol. 2020 Feb;38(2):45-52. doi: 10.1016/j.urolonc.2019.02.010. Epub 2019 Mar 14.
4
Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.经皮冠状动脉介入治疗在癌症患者中的应用：美国的流行率和结局报告。
Eur Heart J. 2019 Jun 7;40(22):1790-1800. doi: 10.1093/eurheartj/ehy769.
5
Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis.雄激素剥夺疗法与前列腺癌患者血栓栓塞事件的关联：系统评价和荟萃分析。
Prostate Cancer Prostatic Dis. 2018 Nov;21(4):451-460. doi: 10.1038/s41391-018-0059-4. Epub 2018 Jul 9.
6
Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis.雄激素剥夺治疗与血栓栓塞事件的关联：一项系统评价与荟萃分析
Urology. 2018 Apr;114:155-162. doi: 10.1016/j.urology.2017.11.055. Epub 2018 Jan 17.
7
Cardiovascular Complications of Androgen Deprivation Therapy for Prostate Cancer.前列腺癌雄激素剥夺治疗的心血管并发症
Curr Treat Options Cardiovasc Med. 2017 Aug;19(8):61. doi: 10.1007/s11936-017-0563-1.
8
Shared Risk Factors in Cardiovascular Disease and Cancer.心血管疾病和癌症的共同风险因素。
Circulation. 2016 Mar 15;133(11):1104-14. doi: 10.1161/CIRCULATIONAHA.115.020406.
9
Global cancer statistics, 2012.全球癌症统计数据，2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
10
Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis.前列腺癌患者雄激素剥夺治疗相关的心血管事件：一项系统评价和荟萃分析。
World J Urol. 2015 Sep;33(9):1281-9. doi: 10.1007/s00345-014-1439-6. Epub 2014 Nov 12.